- Home
- PCVX vs SUZ Comparison
PCVX vs SUZ Comparison
Compare PCVX & SUZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCVX
- SUZ
- Stock Information
- Founded
- PCVX 2013
- SUZ 1924
- Country
- PCVX United States
- SUZ Brazil
- Employees
- PCVX N/A
- SUZ N/A
- Industry
- PCVX Biotechnology: Pharmaceutical Preparations
- SUZ Paper
- Sector
- PCVX Health Care
- SUZ Basic Materials
- Exchange
- PCVX Nasdaq
- SUZ Nasdaq
- Market Cap
- PCVX 13.2B
- SUZ 12.8B
- IPO Year
- PCVX 2020
- SUZ N/A
- Fundamental
- Price
- PCVX $86.51
- SUZ $10.64
- Analyst Decision
- PCVX Strong Buy
- SUZ
- Analyst Count
- PCVX 7
- SUZ 0
- Target Price
- PCVX $147.50
- SUZ N/A
- AVG Volume (30 Days)
- PCVX 1.4M
- SUZ 1.4M
- Earning Date
- PCVX 11-05-2024
- SUZ 10-24-2024
- Dividend Yield
- PCVX N/A
- SUZ 2.25%
- EPS Growth
- PCVX N/A
- SUZ N/A
- EPS
- PCVX N/A
- SUZ 0.60
- Revenue
- PCVX N/A
- SUZ $8,006,653,403.00
- Revenue This Year
- PCVX N/A
- SUZ $14.70
- Revenue Next Year
- PCVX N/A
- SUZ $10.62
- P/E Ratio
- PCVX N/A
- SUZ $16.94
- Revenue Growth
- PCVX N/A
- SUZ N/A
- 52 Week Low
- PCVX $48.24
- SUZ $8.78
- 52 Week High
- PCVX $121.06
- SUZ $12.98
- Technical
- Relative Strength Index (RSI)
- PCVX 23.31
- SUZ 63.75
- Support Level
- PCVX $101.87
- SUZ $9.98
- Resistance Level
- PCVX $107.31
- SUZ $10.59
- Average True Range (ATR)
- PCVX 5.82
- SUZ 0.20
- MACD
- PCVX -2.04
- SUZ 0.01
- Stochastic Oscillator
- PCVX 3.58
- SUZ 78.57
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.
About SUZ Suzano S.A.
Suzano SA produces and sells pulp and a variety of paper products. The company organizes itself into two segments based on product type: Pulp and Paper. The Pulp segment generates the majority of revenue. The firm's product portfolio includes printing and writing paper, paperboard, diapers, and sanitary napkins. The company owns forest land and plants in Brazil, where it harvests timber and turns the timber into pulp and paper in its plants.